Register for a Clinical Trial

Protocol NI03-001
Title Phase 2, Randomized, Double-Blind, Parallel-Group, Dose-Ranging Study to Evaluate the Safety and Efficacy of NI-03 Compared to Placebo in Subjects with Chronic Pancreatitis
Phase II
Area Pancreas
Indication Chronic Pancreatitis
Treatment NI-03, as camostat mesilate and FoipanŽ has been approved in Japan
Requirement
Trial:
Your First Name:
Your Last Name:
Phone Number:
Address:
City:
State:
ZIP Code:
E-mail Address:
Cancel